Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance

Go back to Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
LIGAND PHARMA (NASDAQ: LGND) Delayed: 284.27 --0 (-0%)
Previous Close $284.27    52 Week High $139.79 
Open $284.27    52 Week Low $82.07 
Day High $284.27    P/E 661.09 
Day Low $284.27    EPS $0.43 
Volume 636